Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check27 days agoChange DetectedUpdated contact information is added and the page version is upgraded from v3.0.2 to v3.1.0. The most significant change is the page revision, with a large addition of external contact details.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now includes an estimated timestamp for the last update, replacing the previous exact/alternative wording. Overall impact is a minor update to time-related content.SummaryDifference0.0%

- Check42 days agoChange DetectedUpdated to 35 locations (including Vancouver, WA) and added new contacts/investigators (Susan Papenfuse; Anthony Van Ho, MD; Kartik Konduri, MD); removed the old 34-location entry and former PI; revision bumped to v3.0.2.SummaryDifference2%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations, as well as the introduction of new drug names such as sotorasib and defactinib. However, many previous location details and related topics have been removed.SummaryDifference3%

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.